Pfizer Inc



    Today's change

    -0.09 / -0.25%

    1 year change


    As of Apr 24 2015 21:00 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. April 13, 2015

    Biotech: Making sense of the science

    It was supposed to be a wonder drug. Provenge promised to turn the body’s immune system into a weapon against disease,...

  2. April 9, 2015

    Robey Warshaw makes the big league with role in BG sale

    At the start of this week, a small London-based advisory firm run by two experienced dealmakers was nowhere to be found in...

Special Reports

  1. Combating Cancer

    A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
  2. Combating Neglected Diseases

    While nobody questions the horror of the Ebola epidemic sweeping west Africa, the deat...
Search more Special Reports on this topic.

  1. April 7, 2015

    Big pharma turns to small biotechs for edge in cancer treatment

    Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category of...

  2. April 3, 2015

    Pfizer halts China vaccine sales after import licence not renewed

    US drugmaker Pfizer has halted vaccine sales in China after an import licence for one of its top-selling treatments expired,...

  3. FT Alphaville

    April 3, 2015

    FirstFT (the new 6am Cut)

    You can sign up to receive the email here. It’s a deal – after eight days of talks negotiators came to anagreement for Iran...

  4. March 22, 2015

    Apple and Google stake a claim on big pharma’s turf

    Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had signed...

  5. March 19, 2015

    The charity that matches surplus medicine with acute need

    Pharmaceuticals executives might not seem the most likely recipients of hospitality from HRH the Prince of Wales. The heir...

  6. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  7. March 6, 2015

    Going the extra mile to win a $21bn deal

    The Pharmacyclics executives could hardly believe the turn of events. As they gathered on Wednesday at the drugmaker’s law...

  8. February 25, 2015

    Pharmacyclics considers $19bn sale

    Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people familiar...

  9. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of possible...

  10. February 22, 2015

    Valeant agrees to buy Salix for $14.5bn

    Valeant, the serial pharmaceuticals dealmaker, has agreed to buy Salix in an all-cash transaction that values the...

  11. February 19, 2015

    Sanofi appoints Brandicourt as CEO

    Sanofi has named Olivier Brandicourt of Bayer as its new chief executive, ending a four-month search to replace Chris...

  12. February 11, 2015

    M&A helps lift US healthcare stocks

    Gilead Sciences, the biotech behemoth that has seen its market valuation soar to a cool $145bn, has put in a strong...

  13. February 6, 2015

    Pharma takes a dose of sense from the deals doctor

    Taking the wrong combination of drugs can have serious side effects. The same goes for pharmaceuticals dealmaking. Mix up...

  14. FT Alphaville

    February 6, 2015

    FirstFT (the new 6am Cut)

    You can sign up to receive the email here. Angela Merkel and Francois Hollande will head to Moscow to attempt to break the...

  15. February 5, 2015

    Pfizer: only in America

    M&A begins at home for Pfizer. It may not end there. Jilted by AstraZeneca in 2014 — it had hoped to “invert” into its...

  16. February 5, 2015

    Pfizer’s $17bn Hospira buy could lead to break-up

    Is Pfizer going through a slow-motion break-up? The prevailing view among many analysts on Thursday was Yes, after it...

  17. February 5, 2015

    Q&A: Why has Pfizer bought Hospira?

    Pfizer has searched far and wide for a big acquisition over the past year as Ian Read, chief executive, looks to find...

  18. February 5, 2015

    Pfizer steps up M&A with $17bn deal to buy Hospira

    Pfizer has unveiled its biggest deal since abandoning an ill-fated pursuit of AstraZeneca, agreeing to buy a maker of...

  19. February 4, 2015

    Ackman’s Pershing Square secures seat on Zoetis board

    Bill Ackman, the billionaire hedge fund activist, has parachuted one of his representatives on to the board of Zoetis, the...

  20. February 2, 2015

    Big pharmaceuticals groups faces biosimilars challenge

    Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

  21. January 27, 2015

    Pfizer chief says big acquisition not required

    Pfizer on Tuesday touted its prospects as a standalone company and said it did not need to pursue a big deal, as it warned...

  22. January 21, 2015

    Actavis and Valeant raise prospect of more pharma deals

    Two of the most acquisitive pharmaceuticals groups have pledged to continue pursuing deals in 2015, raising the prospect of...

  23. January 7, 2015

    Pharma takeover battles boost FTSE 100 performance

    Two companies at the centre of takeover battles had the biggest positive impact on the performance of the FTSE 100 last...

  24. December 26, 2014

    Big pharma cashes in as M&A fever sweeps sector

    It was a big year for big pharma as a succession of multibillion-dollar mergers and acquisitions swept the industry. More...

  25. December 22, 2014

    Takeover volumes move to highest post-crisis levels

    Corporate takeover deals surged to their highest levels since the financial crisis this year, with merger and acquisition...

  26. December 10, 2014

    India assumes frontline position in battles over intellectual property rights

    As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

  27. December 10, 2014

    Fraudsters’ robots to cost marketers $6bn

    Marketers will lose $6bn next year to fraudsters who are using networks of robots to exploit the online advertising...

  28. December 9, 2014

    Tax deals raise questions over Ireland’s growth spurt

    Four years after entering a punishing €67bn bailout, the Irish economy is booming again. Gross domestic product expanded at...

  29. December 1, 2014

    ‘Milestone’ in fight against Aids as treatment outpaces infections

    The world has passed an important tipping point in the fight against Aids, according to data showing that more people gained...

  30. November 28, 2014

    How to invest in petcare

    Keeping animals can be a notoriously expensive whim. Beyond the regular costs of feeding a pet are the unexpected veterinary...

  31. November 25, 2014

    AstraZeneca comes into focus as Pfizer’s cooling-off period ends

    It has been a popular pastime among healthcare investors and pharma executives for weeks: guessing the likelihood of Pfizer...

  32. November 18, 2014

    AstraZeneca fleshes out standalone strategy

    AstraZeneca championed its prospects as a standalone company on Tuesday as it gave more details of its strategy to investors...

  33. November 11, 2014

    Ackman-led team takes 10% stake in Zoetis

    The activist investor Bill Ackman is leading a $2.2bn raid on Zoetis, the animal vaccines and medications business spun off...

  34. November 6, 2014

    AstraZeneca: priorities

    $4.20. This little number probably takes up quite a bit of space in the minds of executives at AstraZeneca. Azip, one of the...

  35. November 6, 2014

    AstraZeneca aims to ward off Pfizer by highlighting ‘tax inversion’ risks

    AstraZeneca sought to ward off Pfizer from making a fresh approach for the UK drugmaker by highlighting the increased risk...

  36. November 4, 2014

    Ackman gains ground in fight to force Allergan to sell to Valeant

    Bill Ackman chalked up a big victory in his battle to force Allergan, the maker of blockbuster wrinkle treatment Botox, to...

  37. October 28, 2014

    Pfizer chief: tax inversions still have ‘meaningful value’

    Pfizer has said there is still “meaningful value” to be found in tax inversions despite a White House crackdown that has...

  38. October 24, 2014

    Bellwether UPS rises on ecommerce hopes

    Investors liked what they heard from parcel delivery company and US economic bellwether UPS, which beat third-quarter...

Search for Pfizer Inc and


Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca